Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension

By O'Callaghan Dermot S   Savale Laurent   Yaïïci Azzedine   Natali Delphine   Jaïïs Xavier   Parent Florence   Montani David   Humbert Marc   Simonneau Géérald   Sitbon Olivier  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 10, 2011-07 ,pp. : 1585-1596

Informa Healthcare

Access to resources Recommend Favorite

Endothelin receptor antagonism: a new approach in the treatment of pulmonary hypertension

By  

Inpharma, Vol. 1, Iss. 1311, 2001-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Sitaxsentan, a selective endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension

By Horn Evelyn M   Widlitz Allison C   Barst Robyn J  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1483-1492

Informa Healthcare

Access to resources Recommend Favorite

Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension: Rationale and Place in Therapy

By Price Laura C.   Howard Luke S.G.E.  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 3, 2008-01 ,pp. : 171-185

Adis International

Access to resources Recommend Favorite

The Role of Endothelin-1 in Obstructive Sleep Apnea Syndrome and Pulmonary Arterial Hypertension: Pathogenesis and Endothelin-1 Antagonists

By  

Current Medicinal Chemistry, Vol. 17, Iss. 11, 2010-04 ,pp. : 1059-1066

Bentham Science Publishers

Access to resources Recommend Favorite